GeneDx Holdings Corp. is 1.6x more valuable than InnovAge Holding Corp. by market capitalization ($1.65 B vs $1.02 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | INNV | WGS |
|---|---|---|
| Market cap | $1.02 B | $1.65 B |
| US-listed rank | #2620 | #2251 |
| Revenue (latest FY) | $853.70M | $427.54M |
| Net income (latest FY) | -$30.31M | -$21.00M |
| Net margin | -3.6% | -4.9% |
| SEC filings | 227 | 748 |
GeneDx Holdings Corp. is 1.6x more valuable than InnovAge Holding Corp. by market capitalization ($1.65 B vs $1.02 B).
In their latest fiscal years, InnovAge Holding Corp. reported $853.70M in revenue while GeneDx Holdings Corp. reported $427.54M.
Full pages: InnovAge Holding Corp. and GeneDx Holdings Corp., or browse the full rankings.